Four models read both Evermore audits in full, plus your Bone Voyage numbers, the Boulder location, the pending map-pack correction and the $4,200 symmetry. GPT-5.6 Sol, Gemini 3.1 Pro, Grok 4.5 and DeepSeek v4 Pro, run independently, no model saw another's answer.

They agree more than they disagree, which is unusual and worth taking seriously. Where they split, the split is real and I have made a call on each one.

What all four said, unprompted and independently

The Boulder line is the whole review. Every model led with it. Not one treated it as a correction to slip in. Sol's framing is the one to prepare for, because it is what a skeptical physician actually says out loud:

"Your report told me Boulder was impossible when it may actually be the easiest market available to me. Why should I trust the rest of the prioritization?"

The damage isn't the wrong sentence. It's that the report's central strategic conclusion, that written content is the only route because the map pack is closed everywhere but Longmont, rests on it. Three of the four say the recommendation order is now wrong: Boulder Google Business Profile plus review velocity in the first 30 days beats article one for near-term booked visits. That contradicts the SEO audit's own closing line ("If you only do one thing, do number one," meaning content). I think they're right, and Grok puts it best: run the local push and article one in parallel, don't sequence content first.

Three of four flagged the broken bio-link URL. Sol missed it. Grok: "if the free audit cannot ship a complete sentence, the paid retainer will ship incomplete work."

Neither report contains a dollar. All four called this the reason the audits don't support the ask. They justify a discovery conversation, not a $4,200 execution contract.

$4,200 is underpriced for the scope the reports imply. Unanimous, and none of them was prompted toward it. The reports gesture at two locations, local SEO, three-state content, technical repair, schema, social, LinkedIn, YouTube, email, reviews, events, analytics, paid search, AI visibility and reporting. At $350 a month that is, in Sol's word, fantasy. Sol predicts one of three outcomes: you work far too many unpaid hours, the work goes shallow, or she expects a department and is disappointed.

Name the $4,200 symmetry yourself, early, once. Unanimous, including on the specifics: don't joke about it, don't propose a swap, don't offer marketing months against membership months, keep separate agreements and separate invoices.

Missing from both reports, named by three or four models each: HIPAA and medical advertising compliance, AI and answer-engine visibility, email and owned audience, a paid-search position (even "not yet, and here's why"), named competitors analyzed as businesses rather than review counts in a table, and reviews as a documented system rather than an instruction.

The confidence language on keyword difficulty won't survive a physician who Googles once. All four attacked "close to unguarded" and "the fastest win available to you." DeepSeek is sharpest: difficulty scores are computed from linking domains, not from how Google treats health content, and the live results for "estradiol patch" are Mayo, Cleveland Clinic and Drugs.com. Grok's fix is the practical one, and it's free: bring the actual page-one composition for those two terms to the meeting so difficulty 2 stops being a vendor number and becomes something she can see.

Where they genuinely disagree

How many new members pay for the year. This is the one that matters and the models scattered, because three of them had to guess your membership price. Gemini said one member and you're free. Grok assumed $150 to $250 a month and got two to four. DeepSeek assumed $300 a month and got about two.

You know the number. You paid $4,200 for a year, so Gemini and Sol were anchored right and the other two guessed low. But Gemini's "one patient and I am free" is the version I would not say in the room, and Sol explains why: $4,200 in membership revenue is not $4,200 in profit. She knows her own margins and she will do that subtraction while you're still talking. Sol's table is the honest one:

One member matches your fee in revenue. Two recover it on contribution. Three make it obviously worth doing. That's a sentence a physician will nod at instead of correcting.

Paid search. Gemini wants it as the fastest way to fill Boulder while SEO matures. Sol wants a bounded test and points out the sample-size problem, that ten monthly searches on one term cannot support a campaign. Grok's framing resolves it: silence looks like pure-organic ideology, and "do not buy ads yet, and here is why" is itself a deliverable. Take a position either way, don't leave the $19.74 sitting there unaddressed.

Whether the content strategy is right at all. Gemini alone attacks the spine: a woman Googling "estrogen patch" wants dosage information, not a $4,200 concierge membership, and a cash-pay practice needs ten qualified leads rather than ten thousand informational readers. Sol makes the quieter version, that 87% of search volume across ten selected keywords is not 87% of the addressable patient market. I think Gemini overstates it, because your supplements post already proves the mechanism brings the right reader. But "roughly 99% of the demand is there" should come out of the report. It's the one number in either document I can't defend.

What each model caught alone

Sol was the most technically careful and found four things nobody else did:

• "Ask every satisfied patient, every time" is a compliance problem, not just a weak instruction. Screening for satisfaction before soliciting is selective solicitation. The replacement is a neutral invitation to every eligible patient, no incentives, no gating, and responses that never confirm someone is a patient.
• The page-weight fix doesn't match the diagnosis. The report says roughly 3.2 MB is the page markup itself, then recommends compressing the hero imagery. Those are different problems. Sol also suspects the measurement may be rendered DOM rather than transferred HTML. Worth rechecking with browser network data before you present it as fact.
• The 560-video analysis has no methodology attached. No creator selection rule, no time period, no source, no treatment of outliers. The precision reads as impressive and unverifiable at the same time.
• You write as "we" and you are one person. "We checked," "our tools," "most practices we look at." Unless contractors did the work and you disclose them, that's an unforced credibility risk with someone who is about to ask how big your team is.

DeepSeek and Sol both caught a self-contradiction I confirmed in the text: the report calls sarcopenia "the single most under-defended term we found anywhere in this audit" at line 237, then lists it at difficulty 44 under "Do not write these" at line 293. The advertiser-competition-versus-difficulty explanation is in the document, but the earlier prose was never rewritten to match. She may well read both and ask.

Grok was the strongest on sales mechanics. Its point about the "12 organic visits" framing is one I hadn't considered: the analysis is fine and the placement is commercially self-defeating. You lead with how little traffic she has, which invites "so you want $4,200 to move a number you measured at 12." Put the patient value next to it instead.

The offer: four models, four different answers

All four agree $4,200 is too little for what the reports imply. They disagree completely on what to do about it, and the four answers are worth seeing side by side.

Sol's is the strongest and I'd take it. Its arithmetic is the part that lands: $4,200 a year is $350 a month, and at $125 an hour that's 33.6 hours for the entire year, under three hours a month before software, meetings, revisions and physician review. You cannot fund a medical content program out of that, and the reports promise one.

The sprint solves something the retainer can't. You currently don't know her open capacity, her discovery-call volume, her call-to-member conversion rate, or whether her constraint is awareness, conversion or clinical capacity. Sol's point is that you cannot honestly promise to fill a schedule whose emptiness you haven't measured. A 12-week sprint with a defined end lets you establish that baseline as paid work rather than guessing at it in order to win the deal, and it gives her a decision point instead of an indefinite commitment.

Sol's language for it:

"I am not proposing a vague year of SEO. For $4,200, I will run a 12-week Boulder launch and conversion sprint. I'll correct the highest-impact website issues, establish or optimize the Boulder local presence, install tracking and a compliant review workflow, and publish the first two physician-reviewed search assets. We'll measure discovery calls and memberships by source where your systems allow it. At the end of 12 weeks, you can decide from the data whether ongoing work is justified."

It also insists on an explicit exclusion list, and it's right that without one the two audits read as an invitation to unlimited scope: no ranking or patient guarantees, no redesign, no ongoing social management, no ad budget, no unlimited articles, no legal or HIPAA opinion.

One caution on Sol's own advice: it tells you to promise correct Boulder setup, never map pack placement, because Google location eligibility and verification are not yours to guarantee. That's the right line and it's worth holding even when Gemini's "I am going to bring you the entire Boulder map pack" sounds better in the room.

Where I'd push back on the models

• Gemini's "I am going to bring you the entire Boulder map pack" is a promise you can't make and shouldn't. Same for its instruction not to apologize for the broken link. Fix it, and if she raises it, own it in one sentence. Silent correction of a thing she may have already read is worse than naming it.
• Gemini and DeepSeek both invented details that read as fact: a Boulder lease you haven't confirmed, a page number in a document that has none. Their strategic reads are good, their specifics need checking.
• DeepSeek's 90-day walk-away clause and its suggestion you might need to see another doctor are worth considering but are both bigger moves than the situation calls for.

The consensus script for the symmetry

Four independent models converged on nearly the same thing. Grok's is the tightest:

"I want to name something directly so it does not sit weird. I joined the practice at $4,200 for the year because I want you as my doctor. The marketing work is a separate decision at the same number by coincidence, not as a trade. I do not want a discount on care and I am not asking you to hire me because I am a member. If you want the work, we do it on deliverables and results. If you do not, I am still your patient and that is fine."

Sol adds the piece worth keeping: if she suggests swapping, decline. And Sol's stronger point, which the others soften, is that the clinical relationship is harder to replace than a $4,200 contract. If the dual relationship makes either of you uncomfortable, protecting the medical one is the correct trade.

The objection you're least equipped for

All four named the same one: "How many paying menopause patients have you acquired for a practice like mine?" The answer is zero, and all four say don't dodge it. Grok's version:

"No. You would be early in this vertical. What I have done is take a physical operation in Mexico to DR 62 and more than four thousand page-one rankings into the US and Canada against national nonprofits. Your problem is the same shape: one or two addresses, a three-state licence footprint, and demand that does not live in city-plus-keyword searches. I will not show you a menopause case study I do not have."

Before Monday

In the order the models would rank them:

1. Fix the broken bio-link URL in the social audit and reload the portal.
2. Rewrite every map-pack geography sentence for two locations, and add the Boulder pack table with the 11, 3 and 4 review counts named.
3. Delete "roughly 99% of the demand," and soften "unguarded" and "fastest win" to something you can defend against a live search result.
4. Build the one-page payback with your real membership number and the contribution-margin sensitivity. One matches, two recovers, three wins.
5. Decide whether $4,200 is a year or a 12-week sprint, and write the scope card either way: what it includes, what it excludes, what the cadence is. Every model said walking in without this is the failure mode.
6. Reconcile the sarcopenia contradiction.
7. Prepare the symmetry script and the no-case-study answer as spoken lines, not documents.

Sol's seven questions are the ones to ask her before you present anything, because the answers decide whether the sprint is even aimed at the right thing: how many new members can she responsibly onboard in 90 days, which opening matters most (Boulder, Longmont or telehealth), what a new member is worth annually, how many discovery calls she gets now, roughly what share become members, where her most recent members heard about her, and who approves medical content and how fast.

Optional and cheap: pull the live page-one results for "estradiol patch" and "estrogen patch" and bring them. It converts your weakest claim into your most credible one.

Reviews run 2026-08-08 on OpenRouter. GPT-5.6 Sol, Gemini 3.1 Pro, Grok 4.5, DeepSeek v4 Pro. 13,047 words returned, $0.54 total. Sol's first run hit its output ceiling mid-answer and its sections on the offer and the meeting were re-run separately.